OR01-01 Oral, Once-daily, Paltusotine (Non-peptide Selective Somatostatin Receptor Subtype 2 Agonist) Therapy In Patients With Acromegaly Is Associated With Long-term Biochemical And Symptom Control And Is Preferred Over Injectable Somatostatin-Receptor Ligands
Gadelha, Monica R, Randeva, Harpal Singh, Gordon, Murray B, Doknic, Mirjana, Mezosi, Emese, Toth, Miklos, Boguszewski, Cesar Luiz, Ferrara-Cook, Christine T, Casagrande, Alessandra, Krasner, Alan
Published in Journal of the Endocrine Society (05.10.2023)
Published in Journal of the Endocrine Society (05.10.2023)
Get full text
Journal Article
12537 Once Daily Oral Atumelnant (CRN04894) Induces Rapid And Profound Reductions Of Androstenedione And 17-Hydroxyprogesterone In Participants With Classical Congenital Adrenal Hyperplasia: Initial Results From A 12-Week, Phase 2, Open-Label Study
Joseph Auchus, Richard, James Trainer, Peter, Jean Lucas, Kathryn, Bruera, Dario, Marko, Jamie, Ayala, Alejandro, Wu, Yang, Ferrara-Cook, Christine T, De La Torre, Eduardo, Krasner, Alan, Lagast, Hjalmar, Luo, Rosa, Bachega, Tania A S S, Struthers, R Scott, Betz, Stephen F, Srirangalingam, Umasuthan
Published in Journal of the Endocrine Society (05.10.2024)
Published in Journal of the Endocrine Society (05.10.2024)
Get full text
Journal Article